CO5090842A1 - Derivados ftalacinicos inhibidores de la fosfodiesterasa 4 - Google Patents

Derivados ftalacinicos inhibidores de la fosfodiesterasa 4

Info

Publication number
CO5090842A1
CO5090842A1 CO99045518A CO99045518A CO5090842A1 CO 5090842 A1 CO5090842 A1 CO 5090842A1 CO 99045518 A CO99045518 A CO 99045518A CO 99045518 A CO99045518 A CO 99045518A CO 5090842 A1 CO5090842 A1 CO 5090842A1
Authority
CO
Colombia
Prior art keywords
alkyl
aryl
heterocycle
optionally substituted
alkoxy
Prior art date
Application number
CO99045518A
Other languages
English (en)
Inventor
Mauro Napoletano
Gabriele Norcini
Giancarlo Grancini
Franco Pellacini
Gian Marco Leali
Gabriele Morazzoni
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of CO5090842A1 publication Critical patent/CO5090842A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/34Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)

Abstract

Compuestos con fórmula (I) <EMI FILE="99045518_1" ID="1" IMF=JPEG >(I)donde ------ es un enlace simple o doble; Z es NH, metileno, una cadena alquilénica (C2-C6) opcionalmente ramificada y/o insaturada y/o interrumpida por un residuo (C5-C7) cicloalquilo; un es fenilo o heterociclo opcionalmente sustituido por uno o más sustituyentes seleccionados entre grupos oxo, nitro, carboxi y átomos de halógeno, o un grupo COR4 donde R4 es hidroxi, (C1-C6 )-alcoxi, amino opcionalmente sustituido por uno o dos grupos (C1-C6)alquilo o por hidroxi; R es un grupo (C1-C6)alquilo o poliflúor(C1-C6 )alquilo; R1 está ausente cuando ------ es un enlace doble o, cuando ------ es un enlace simple, es (a) hidrógeno; (b) (C1-C6)alquilo opcionalmente sustituido por arilo, por heterociclo o por un grupo COR5 donde R5 es hidroxi, (C1-C4)alcoxi o hidroxamino; (c)-COR6 donde R6 es hidrógeno, arilo, aril-(C1-C6)alquilo, amino opcionalmente alquiloado o monohidroxilato, hidroxi, (C1-C4)alcoxi, carboxi, (C1-C4)alcoxicarbonilo, HN=C-NH2, o (C1-C4)alquilo opcionalmente sustituido por heterociclo; (d)(C1-C4)-alquilosulfonil; R2 representa dos átomos de hidrógeno o un grupo =O cuando ------ es un enlace simple, o, cuando ------ es un enlace doble, R2 es hidrógeno, ciano, (C1-C4)alcoxicarbonilo, amido, opcionalmente sustituido por arilo o heterociclo, (C1-C8)alquilo, (C2-C8)alquenilo o (C2-C8)alquinilo opcionalmente ramificado y/o sustituido por arilo o heterociclo; ariloxi, heterocicliloxi, aril-(C1-C4)alcoxi, heterociclil-((C1-C4)alcoxi, amino sustituido por uno o dos grupos (C1-C4)-alquilo, arilamino, heterociclilamino, aril-(C1-C4)alquiloamino, heterociclil-(C1-C4)-alquiloamino; R3 es hidrógeno, o un (C1-C8)alquilo, (C2-C8)alquenilo o (C2-C8)alquinilo grupo opcionalmente sustituido por hidroxi, oxo, arilo o heterociclo, y opcionalmente interrumpido por uno o más heteroátomos o heterogrupos; los derivados N?O de los compuestos con fórmula I y sus sales farmacéuticamente aceptables son Inhibidores de la PDE 4.
CO99045518A 1998-07-21 1999-07-19 Derivados ftalacinicos inhibidores de la fosfodiesterasa 4 CO5090842A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98MI001670A ITMI981670A1 (it) 1998-07-21 1998-07-21 Derivati ftalazinici inibitori della fosfodiesterasi 4

Publications (1)

Publication Number Publication Date
CO5090842A1 true CO5090842A1 (es) 2001-10-30

Family

ID=11380474

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99045518A CO5090842A1 (es) 1998-07-21 1999-07-19 Derivados ftalacinicos inhibidores de la fosfodiesterasa 4

Country Status (35)

Country Link
US (2) US6329370B1 (es)
EP (2) EP1371648A1 (es)
JP (1) JP2002521370A (es)
KR (1) KR20010087161A (es)
CN (1) CN1127486C (es)
AP (1) AP2000001993A0 (es)
AR (1) AR019409A1 (es)
AT (1) ATE279397T1 (es)
AU (1) AU765457B2 (es)
BG (1) BG105063A (es)
BR (1) BR9911175A (es)
CA (1) CA2338044A1 (es)
CO (1) CO5090842A1 (es)
DE (1) DE69921139T2 (es)
EA (1) EA200100062A1 (es)
EE (1) EE200100039A (es)
HK (1) HK1039124B (es)
HR (1) HRP20010057A2 (es)
HU (1) HUP0102646A3 (es)
ID (1) ID28874A (es)
IL (1) IL139490A0 (es)
IS (1) IS5772A (es)
IT (1) ITMI981670A1 (es)
MX (1) MXPA01000670A (es)
NO (1) NO318988B1 (es)
NZ (1) NZ507926A (es)
OA (1) OA11582A (es)
PA (1) PA8478301A1 (es)
PE (1) PE20000755A1 (es)
PL (1) PL345187A1 (es)
SK (1) SK1002001A3 (es)
TW (1) TW509682B (es)
UA (1) UA68383C2 (es)
WO (1) WO2000005218A1 (es)
YU (1) YU77500A (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4950519A1 (es) * 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
IT1296984B1 (it) * 1997-12-19 1999-08-03 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4
ITMI981671A1 (it) 1998-07-21 2000-01-21 Zambon Spa Derivati ftalazinici inibitori della fosfodisterasi 4
DE19921567A1 (de) * 1999-05-11 2000-11-16 Basf Ag Verwendung von Phthalazine-Derivaten
DE19963607B4 (de) * 1999-12-23 2005-12-15 Schering Ag Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen
ITMI20000261A1 (it) * 2000-02-16 2001-08-16 Zambon Group Processo per la preparazione di piridiniliden-ftalidi
WO2001079181A2 (en) * 2000-04-13 2001-10-25 Annovis, Inc. Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors
US6525049B2 (en) * 2000-07-05 2003-02-25 Pharmacia & Upjohn Company Pyrroloquinolones as antiviral agents
WO2002044157A2 (en) * 2000-12-01 2002-06-06 Iconix Pharmaceuticals, Inc. Parb inhibitors
ITMI20022739A1 (it) * 2002-12-23 2004-06-24 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4.
ITMI20022738A1 (it) * 2002-12-23 2004-06-24 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4.
JP4790594B2 (ja) * 2003-02-25 2011-10-12 トポターゲット ユーケー リミテッド Hdacインヒビターとしての、二環式ヘテロアリール基を含むヒドロキサム酸化合物
ITMI20031451A1 (it) * 2003-07-16 2005-01-17 Zambon Spa Derivati diidro-ftalazinici inibitori della fosfodiesterasi 4
AU2005260102A1 (en) * 2004-05-08 2006-01-12 Novartis International Pharmaceutical Ltd. 3-aryl-5,6-disubstituted pyridazines
EP1833803A4 (en) * 2005-01-03 2009-08-05 Myriad Genetics Inc PHARMACEUTICAL COMPOUNDS COMPRISING CASPASE ACTIVATORS AND INDUCERS OF APOPTOSIS AND THE USE THEREOF
RU2008119323A (ru) 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Фармацевтические композиции мускаринового рецептора
WO2008061108A2 (en) 2006-11-15 2008-05-22 Forest Laboratories Holdings Limited Phthalazine derivatives
WO2010019417A2 (en) * 2008-08-13 2010-02-18 Boehringer Ingelheim International Gmbh Chymase inhibitors
CN102108078B (zh) * 2009-12-24 2013-10-30 沈阳药科大学 1,4-取代酞嗪类化合物及其制备方法和用途
CN104203919A (zh) * 2011-11-09 2014-12-10 艾伯维德国有限责任两合公司 可用作10a型磷酸二酯酶的抑制剂的杂环甲酰胺类

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2063249A (en) * 1979-10-09 1981-06-03 Mitsubishi Yuka Pharma 4-Phenylphthalazine derivatives
JPH03106873A (ja) * 1989-09-20 1991-05-07 Morishita Pharmaceut Co Ltd 1―ピリジルフタラジン誘導体及びそれらを含有する血小板凝集抑制剤
DE69105572T2 (de) * 1990-03-30 1995-05-11 Mitsubishi Chem Ind 4-Phenylphthalazin-Derivate.
EP0634404A1 (en) 1993-07-13 1995-01-18 Rhone Poulenc Agriculture Ltd. Phtalazin derivatives and their use as pesticides
ATE267174T1 (de) * 1994-08-09 2004-06-15 Eisai Co Ltd Kondensierte pyridazinverbindungen
IT1296984B1 (it) * 1997-12-19 1999-08-03 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4

Also Published As

Publication number Publication date
BG105063A (en) 2001-07-31
SK1002001A3 (en) 2001-12-03
US6329370B1 (en) 2001-12-11
MXPA01000670A (es) 2002-05-14
PA8478301A1 (es) 2000-09-29
AR019409A1 (es) 2002-02-20
HK1039124A1 (en) 2002-04-12
EP1371648A1 (en) 2003-12-17
EP1097142A1 (en) 2001-05-09
UA68383C2 (en) 2004-08-16
WO2000005218A1 (en) 2000-02-03
IS5772A (is) 2000-12-15
PL345187A1 (en) 2001-12-03
JP2002521370A (ja) 2002-07-16
CN1305467A (zh) 2001-07-25
EE200100039A (et) 2002-06-17
OA11582A (en) 2004-07-26
EP1097142B1 (en) 2004-10-13
TW509682B (en) 2002-11-11
CN1127486C (zh) 2003-11-12
ITMI981670A0 (it) 1998-07-21
US6492360B1 (en) 2002-12-10
ATE279397T1 (de) 2004-10-15
AU5281099A (en) 2000-02-14
CA2338044A1 (en) 2000-02-03
DE69921139T2 (de) 2005-10-13
NO20010331D0 (no) 2001-01-19
HUP0102646A2 (hu) 2001-12-28
AP2000001993A0 (en) 2000-12-31
HK1039124B (zh) 2005-04-01
ITMI981670A1 (it) 2000-01-21
ID28874A (id) 2001-07-12
NO318988B1 (no) 2005-05-30
BR9911175A (pt) 2001-03-20
PE20000755A1 (es) 2000-09-01
AU765457B2 (en) 2003-09-18
YU77500A (sh) 2002-11-15
HUP0102646A3 (en) 2003-01-28
IL139490A0 (en) 2001-11-25
KR20010087161A (ko) 2001-09-15
NZ507926A (en) 2002-10-25
DE69921139D1 (de) 2004-11-18
NO20010331L (no) 2001-03-20
HRP20010057A2 (en) 2002-04-30
EA200100062A1 (ru) 2001-08-27

Similar Documents

Publication Publication Date Title
CO5090842A1 (es) Derivados ftalacinicos inhibidores de la fosfodiesterasa 4
MY135309A (en) Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
CO5261497A1 (es) Gama-hidroxi-2-(fluoroalquilamino-carbonil)-1-piperazino pentanamidas y sus usos
CO4770975A1 (es) Derivados de quinazolina sustituidos
HUP0002954A2 (hu) Farnezil-protein transzferáz új N-szubsztituált-karbamid inhibitorai
UA41247C2 (uk) Похідні n-фенілпіразолу
CO5080782A1 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa
HUP0400828A2 (hu) Kondenzált heterociklikus aminopirimidinek, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
EA200100061A1 (ru) Производные фталазина в качестве ингибиторов фосфодиэстеразы 4
CO5170518A1 (es) Compuestos n-(benzocicloalquilo) derivados de amino aralifaticos
CO5580824A2 (es) Derivados de fenil o heteroaril amino alcano como antagonis- tas del receptor ip
WO2006109075A3 (en) Hydroxybenzamide derivatives and their use as inhibitors of hsp90
MY119238A (en) 8-quinolinzanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
DK1442019T3 (da) Amidderivater som glycogensynthasekinase 3- beta-inhibitorer
CO5700733A2 (es) Acidos aminocarboxilicos sustituidos
DE69923692D1 (de) Wachstumshormon-freisetzende oxindolderivate
CY1108313T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
CO4900050A1 (es) Pirrolcarboxanilidas fusionadas; una nueva clase de ligan- dos receptores cerebrales de gaba
CO5251431A1 (es) Derivados quimicos y su aplicacion como agente antitelomerasa
UY25987A1 (es) Procedimiento para preparar complejo del inhibidor de ras-fa rnesiltransferasa y sulfobutileter-7-beta-ciclodextrina o 2- hidroxipropil-beta-ciclodextrina y método
NO931433D0 (no) 4,1-benzoksazepinderivater og deres anvendelse
WO2004046113A3 (en) Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
CO4990932A1 (es) Derivados de 2,1,3-benzotiadiazol y proceso para su preparacion
DK0492369T3 (da) Hidtil ukendte tricycliske amino- og nitro-forbindelser med ACE-hæmmende virkning
AR043055A1 (es) Derivados de 1-(4-benzil-piperazin-1-il)-3- fenil-propenona